Summary

来自人类脐带血内皮细胞集落形成细胞的表型和功能特性

Published: April 13, 2012
doi:

Summary

具有强大的克隆增殖潜能内皮细胞集落形成细胞(ECFCs)循环内皮细胞,显示内在<em>在体内</em>血管形成能力。会CB衍生内皮细胞生长的表型和功能特性,是重要的识别和分离<em>善意</em> ECFCs修复受损的组织,为潜在的临床应用。

Abstract

新的血液通过血管生成,血管,小动脉血管的形成长期的看法,最近已检讨1。循环内皮祖细胞(EPCs)的存在,首次发现麻原等。成人外周血中,在1997年2将注入新的假说和血管再生和修复策略。内皮祖细胞是罕见的,但正常的血液循环的组成部分,血管形成或血管重塑的网站,并在很大程度上促进通过旁分泌刺激现有的血管壁细胞中的3任产后的血管生成,血管生成,或小动脉。没有特定的标记,以确定一个EPC已经确定,目前该领域的国家是理解,许多类型的细胞,包括血管形成的造血干细胞和祖细胞,循环血管细胞,Tie2的+单核细胞 ,髓系祖CELLS,肿瘤相关巨噬细胞和M2激活巨噬细胞在多种临床前动物模型系统和人类受试者在许多疾病状态4,5,刺激血管生成过程的参与。内皮细胞集落形成细胞(ECFCs)是可行的罕见循环内皮细胞,特点是强大的克隆增殖潜能,二级和三级集落形成能力后replating,为6-8免疫缺陷小鼠移植后体内血管形成的内在能力。虽然ECFCs已成功地从外周血中分离的健康成人受试者,健康新生儿脐带血(CB)的,和血管壁无数人的动脉和静脉血管6-9,CB拥有ECFCs 7的频率最高,显示最强大的克隆增殖潜能和耐用,功能血管的形式在体内 8,10-13。而推导从成人外周血ECFC已提交14,15,在这里,我们描述的推导方法,克隆,扩展,并在体外以及从人脐CB ECFCs 体内表征。

Protocol

试剂和溶液肌电图-2媒体(龙沙,猫。编号:CC-3162包含的EBM-2培养基和临时股东大会-2 SingleQuot的套件补充,生长因子) EBM-2(龙沙,货号CC-3156),辅以整个SingleQuot套件补充和生长因子(龙沙,猫。CC-4176号),胎牛血清(FBS)和10%(V / V) 1%(V / V),青霉素(1万U /毫升)/链霉素(10,000微克/毫升)/两性霉素(25微克/毫升)。在4°C存储长达1个月建议的临?…

Discussion

假定内皮祖细胞的表型和功能特性,是重要的,以确定是否真正是能够克隆,并连续在文化再镀的的善意 ECFCs和耐用和功能, 在体内植入血管引起。脐血丰富与ECFCs这些循环细胞老化或疾病的10下降浓度。最近的研究表明,ECFC可能在血管修复或再生血管损伤,心肌梗死,或视网膜病变17-19的情况下发挥重要作用。

在这里,我们描述了简单?…

Disclosures

The authors have nothing to disclose.

Acknowledgements

尤德博士是EndGenitor科技公司的顾问和Rimedion科技公司的董事会成员

Materials

Name of the reagent Company Catalogue number
Heparin Sodium Injection, USP APP Pharmaceuticals 504031
Ficoll-Pague Amersham Biosciences 17-1440-03
Mixing cannula Maersk Medical 500.11.012
EGM-2 Lonza CC-3162
Defined FBS Hyclone SH30070.03
TrypLE express Gibco 12605
Rat type I collagen BD Biosciences 354236
Matrigel BD Biosciences 356234
FcR Block Miltenyi Biotech 130-059-901
hCD31, FITC conjugated BD Pharmingen 555445
hCD45, FITC conjugated BD Pharmingen 555482
hCD14, FITC conjugated BD Pharmingen 555397
hCD144, PE conjugated eBioscience 12-1449-80
hCD146, PE conjugated BD Pharmingen 550315
hCD105, PE conjugated Invitrogen MHCD10504
Ms IgG1,k antibody, FITC conjugated BD Pharmingen 555748
Ms IgG1,k antibody, PE conjugated BD Pharmingen 559320
Ms IgG2a,k antibody, FITC conjugated BD Pharmingen 555573
Anti-human CD31 Dako clone JC70/A
Anti-mouse CD31 BD Pharmingen 553370
0.22-μm vacuum filtration system Millipore SCGPU05RE
Glacial acetic acid, 17.4N Fisher A38-500
Antibiotic-Antimycotic Invitrogen 15240-062
Fetal bovine serum (FBS) Hyclone SH30070.03
IHC Zinc Fixative BD Biosciences 550523
Sytox green reagent Invitrogen S33025
Cloning cylinders, sterile Fisher Scientific 07-907-10

References

  1. Carmeliet, P., Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature. 473, 298-307 (2011).
  2. Asahara, T. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275, 964-967 (1997).
  3. Urbich, C., Dimmeler, S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95, 343-353 (2004).
  4. Critser, P. J., Voytik-Harbin, S. L., Yoder, M. C. Isolating and defining cells to engineer human blood vessels. Cell. Prolif. 44, 15-21 (2011).
  5. Matthias, M., David, N., Josef, N. From bench to bedside: what physicians need to know about endothelial progenitor cells. Am. J. Med. 124, 489-4897 (2011).
  6. Ingram, D. A. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood. 105, 2783-276 (2005).
  7. Ingram, D. A. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 104, 2752-2760 (2004).
  8. Yoder, M. C. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 109, 1801-1809 (2007).
  9. Reinisch, A., Strunk, D. Isolation and Animal Serum Free Expansion of Human Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) and Endothelial Colony Forming Progenitor Cells (ECFCs. J. Vis. Exp. (32), e1525 (2009).
  10. Au, P. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood. 111, 1302-135 (2008).
  11. Critser, P. J., Kreger, S. T., Voytik-Harbin, S. L., Yoder, M. C. Collagen matrix physical properties modulate endothelial colony forming cell-derived vessels in vivo. Microvasc. Res. 80, 23-30 (2010).
  12. Melero-Martin, J. M. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ. Res. 103, 194-202 (2008).
  13. Melero-Martin, J. M. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 109, 4761-4768 (2007).
  14. Hofmann, N. A., Reinisch, A., Strunk, D. Isolation and Large Scale Expansion of Adult Human Endothelial Colony Forming Progenitor Cells. J. Vis. Exp. (32), e1524 (2009).
  15. Lin, Y., Weisdorf, D. J., Solovey, A., Hebbel, R. P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105, 71-77 (2000).
  16. Witting, S. R. Efficient Large Volume Lentiviral Vector Production Using Flow Electroporation. Hum. Gene. Ther. , (2011).
  17. Yoon, C. H. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation. , 112-1618 (2005).
  18. Dubois, C. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J. Am. Coll. Cardiol. 55, 2232-2243 (2010).
  19. Medina, R. J., O’Neill, C. L., Humphreys, M. W., Gardiner, T. A., Stitt, A. W. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 5906-5913 (2010).
check_url/3872?article_type=t

Play Video

Cite This Article
Prasain, N., Meador, J. L., Yoder, M. C. Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood. J. Vis. Exp. (62), e3872, doi:10.3791/3872 (2012).

View Video